Abbott Libre Rio
Over-the-counter glucose system announced for adults with type 2 diabetes who do not use insulin.
Keep in mind FDA clearance is not proof of released sales. Lingo and Libre-family specifications are not substituted.
Compare wearables
Compare up to 10 devices across categories. Keep the purpose and the source beside the numbers.
How price order works
Lowest recorded store prices take priority over announced or launch prices, within the selected source market. Currencies use the dated EUR reference rates. Deposits and recurring charges are excluded from price order; missing prices stay last. Original price records remain visible.
At a glance
The differences that matter
Dexcom G7
Prescription continuous glucose system for people with diabetes, including children from age two.
Keep in mind No unverified insurance copay is treated as a device retail price.
Published specifications and documented constraints. See the full comparison below for prices and sources.
Scroll across the table to compare every model
| Biosensors & healthAdd a model |  |  |
|---|---|---|
| Prices · all markets | Price not verified 0 offer records & sourcesNo verified price in this audit. | £51.25 GBP≈ €61 EUR · $68 USDECB 2026-10-12UK · Store price · Manufacturer listing; checkout and exact stock not independently verified 1 offer records & sources£51.25 GBP≈ €61 EUR · $68 USDECB 2026-10-12 UK · Store price Manufacturer listing; checkout and exact stock not independently verifiedDexcom One original G7 10-day sensor; receiver excluded UK maker-store one 10-day G7 sensor is GBP 51.25 excluding VAT. This offer is original G7, not G7 15 Day; receiver and optional recurring plans are separate.Check merchant offer ↗Price source ↗ Checked 2026-10-13 |
| Designed for | Over-the-counter glucose system announced for adults with type 2 diabetes who do not use insulin. ↗ | Prescription continuous glucose system for people with diabetes, including children from age two. ↗ |
| Form factor | Continuous glucose biosensor ↗ | Wearable glucose sensor ↗ |
| Measurement | Interstitial glucose monitoring ↗ | Continuous interstitial glucose ↗ |
| Intended Users | Adults 18+ with type 2 diabetes, not using insulin ↗ | People with type 1, type 2 or gestational diabetes; ages 2+ ↗ |
| USRegulatory | FDA OTC iCGM clearance announced June 2024 ↗ | Not applicable to this category |
| Interface | CGM system for glucose-pattern review ↗ | Compatible app or receiver ↗ |
| Connectivity | Not applicable to this category | Compatible pump, pen and health-app integrations ↗ |
| Purpose Class | Not applicable to this category | Medical CGM ↗ |
| Availability | Official 2024 clearance announcement confirmed; no current exact Libre Rio retail launch or price verified. | Exact original G7 UK manufacturer shop offer verified. This price excludes VAT and is not the US G7 15 Day model. |
| Important context |
|
|
| Editorial pick & release | No editorial ranking recorded | No editorial ranking recorded |
| Evidence | Manufacturer source Checked 2026-10-13 | Manufacturer source Checked 2026-10-13 |
Battery claims use different conditions and are not a controlled benchmark. “Not verified” is an evidence gap, not a missing feature. Prices are dated regional snapshots. Deposits, bundles and historical launch prices are labelled. Brightness measurement methods and battery workloads vary by manufacturer.